Study ASKB2018001: A randomized, open-labeled, historically controlled, multi-site clinical field study to assess the effectiveness and safety of three different doses of ASKB626 for the management of anemia in cats with IRIS Stage 2 or 3 CKD
|Effective start/end date
|2/1/19 → 7/30/20
- ALCHERABIO, LLC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.